Key facts
- People Science’s last known valuation is $20.0M (Dec 2022).
- It has raised $11.0M; the latest was Seed Round ($1.8M) in Jan 2025.
- Notable investors include Lifeforce Capital, Bluestein Ventures, Acre Venture Partners, FORM Life Ventures, FTW Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for People Science
- ·The full record, as it builds
Funding rounds
No funding rounds for People Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About People Science
Operator of a technology-enabled clinical research company intended to provide a scaled research and development platform for alternative medicines. The company connects health-minded people with doctors and research scientists and assists manufacturers to develop products backed by scientific testing and research, enabling customers to understand which alternative medicines can help them on their path to wellness.
- Sector
- Healthcare
- HQ
- West Hollywood, CA, United States
- Founded
- 2019
- Employees
- 13
- Website
- peoplescience.health/
- Ownership
- Privately Held (backing)
People Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in People Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on People Science in its N-PORT filings yet. We sweep new filings monthly.